Recurrence After Subtotal Resection of NF‐2‐Associated Versus Sporadic Vestibular Schwannomas: A Matched‐Cohort Analysis
Otolaryngology–Head and Neck Surgery · 2026-07 · 175 (1) · 181-189
DOI: 10.1002/ohn.70242 ↗At a glance
Vergleichsstudie in Otolaryngology–Head and Neck Surgery, published online on 2026-04-14. Written by Stephanie Younan and 13 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA. Major MEDLINE topics: Neuroma, Acoustic, Neoplasm Recurrence, Local, Neurofibromatosis 2. Cited 1 times so far (Crossref); 30 references.
Abstract (original language)
Objective
This study compares recurrence patterns after subtotal resection (STR) of neurofibromatosis type 2 (NF‐2)‐associated versus sporadic vestibular schwannomas (VSs) and aims to identify independent predictors of recurrence. Study Design Retrospective matched‐cohort study.
Setting
Single tertiary academic medical center.
Methods
We identified patients who underwent STR for VS between 2004 and 2024. A cohort of 21 NF‐2 patients was matched to 79 sporadic controls based on age, sex, and tumor size (Koos grade). Preoperative and postoperative tumor volumes were calculated and included as covariates in survival analyses. The primary outcome was recurrence‐free survival, analyzed using Kaplan‐Meier methods and Cox proportional hazards regression.
Results
The NF‐2 cohort experienced a higher overall recurrence rate than the matched sporadic cohort (42.9% vs 16.5%). In a multivariable Cox regression model adjusting for clinical and volumetric covariates, NF‐2 status emerged as a strong, significant independent predictor of recurrence (adjusted hazard ratio [aHR] 4.83; 95% CI 1.25‐18.62; P = .022). This association was absent in the full, unmatched cohort, highlighting the importance of the matched design. No other variables, including postoperative adjuvant radiation, were significant predictors in the final matched model.
Conclusion
In this matched‐cohort analysis, the intrinsic biology of germline NF2 is a powerful, independent driver of tumor recurrence following STR. This finding, unmasked by controlling for key confounders, suggests that the elevated recurrence risk in NF‐2 patients is a direct consequence of the underlying genetic disorder. These results underscore the distinct natural history of NF‐2‐associated tumors and support the need for lifelong surveillance.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
- Department of Neurological Surgery, University of California-San Francisco, San Francisco, California, USA.
ORCID profiles: Stephanie Younan, Nicole T Jiam
Cite
APA
Younan, S., Chang-Chien, C., Kaufman, L., Ramesh, R., Al-Adli, N., Limb, C. J., Sharon, J. D., McDermott, M. W., Goldschmidt, E., Cheng, Y. S., Theodosopoulos, P., Na, B., Morshed, R. A., & Jiam, N. T. (2026). Recurrence After Subtotal Resection of NF‐2‐Associated Versus Sporadic Vestibular Schwannomas: A Matched‐Cohort Analysis. Otolaryngology–Head and Neck Surgery, 175(1), 181-189. https://doi.org/10.1002/ohn.70242
Vancouver
Younan S, Chang-Chien C, Kaufman L, Ramesh R, Al-Adli N, Limb CJ, et al. Recurrence After Subtotal Resection of NF‐2‐Associated Versus Sporadic Vestibular Schwannomas: A Matched‐Cohort Analysis. Otolaryngology–Head and Neck Surgery. 2026;175(1):181-189. doi:10.1002/ohn.70242
BibTeX
@article{Younan2026,
author = {Younan, Stephanie and Chang-Chien, Connie and Kaufman, Lourdes and Ramesh, Rithvik and Al-Adli, Nadeem and Limb, Charles J and Sharon, Jeffrey D and McDermott, Michael W and Goldschmidt, Ezequiel and Cheng, Yew Song and Theodosopoulos, Philip and Na, Brian and Morshed, Ramin A and Jiam, Nicole T},
title = {Recurrence After Subtotal Resection of NF‐2‐Associated Versus Sporadic Vestibular Schwannomas: A Matched‐Cohort Analysis},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
volume = {175},
number = {1},
pages = {181--189},
doi = {10.1002/ohn.70242}
}
EUVIMED